Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 2/2017

12.07.2017

Short and long-term outcomes after combined intravenous thrombolysis and mechanical thrombectomy versus direct mechanical thrombectomy: a prospective single-center study

verfasst von: Giovanni Merlino, Massimo Sponza, Benedetto Petralia, Alessandro Vit, Vladimir Gavrilovic, Andrea Pellegrin, Michele Rana, Iacopo Cancelli, Sara Naliato, Simone Lorenzut, Roberto Marinig, Ferdinando Calzolari, Roberto Eleopra

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Recent clinical trials demonstrated that mechanical thrombectomy (MT) using second-generation endovascular devices has beneficial effects in acute ischemic stroke (AIS) due to large vessel occlusion (LVO). However, it remains controversial if intravenous thrombolysis (IVT) prior to MT is superior compared to direct mechanical thrombectomy (DMT). The aims of this study were to compare short and long-term outcomes between IVT + MT and DMT patients. We prospectively recruited AIS patients with LVO in the anterior or posterior circulation eligible for MT with and without prior IVT. Modified Rankin Scale (mRS) and mortality were assessed at baseline, at discharge, 90-days and 1-year after stroke. Favorable outcome was defined as a mRS score ≤2. Of the 66 patients included, 33 (50%) were in IVT + MT group and 33 (50%) were in DMT group. Except for a higher prevalence of patients using anticoagulants at admission in DMT group, baseline characteristics did not differ in the two groups. Procedural characteristics were similar in IVT + MT and DMT group. Rate of favorable outcome was significantly higher in IVT + MT patients than DMT ones both 90-days (51.5 vs. 18.2%; p = 0.004) and 1-year (51.5 vs. 15.2%; p = 0.002) after stroke. DMT patients were six times more likely to die during the 1-year follow-up compared to IVT + MT patients. This study suggests that bridging therapy may improve short and long-term outcomes in patients eligible for endovascular treatment. Further studies with larger patient numbers and randomized design are needed to confirm our findings.
Literatur
2.
Zurück zum Zitat Bhatia R, Hill MD, Shobha N, Menon B, Bal S, Kochar P et al (2010) Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 41:2254–2258. doi:10.1161/STROKEAHA.110.592535 CrossRefPubMed Bhatia R, Hill MD, Shobha N, Menon B, Bal S, Kochar P et al (2010) Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 41:2254–2258. doi:10.​1161/​STROKEAHA.​110.​592535 CrossRefPubMed
3.
Zurück zum Zitat Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, EXTEND-IA Investigators et al. (2015) Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 372:1009–1018. doi:10.1056/NEJMoa1414792 CrossRefPubMed Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, EXTEND-IA Investigators et al. (2015) Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 372:1009–1018. doi:10.​1056/​NEJMoa1414792 CrossRefPubMed
4.
Zurück zum Zitat Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, MR CLEAN Investigators et al (2015) A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372:11–20. doi:10.1056/NEJMoa1411587 CrossRefPubMed Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, MR CLEAN Investigators et al (2015) A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372:11–20. doi:10.​1056/​NEJMoa1411587 CrossRefPubMed
5.
Zurück zum Zitat Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, ESCAPE Trial Investigators et al. (2015) Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372:1019–1030. doi:10.1056/NEJMoa1414905 CrossRefPubMed Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, ESCAPE Trial Investigators et al. (2015) Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372:1019–1030. doi:10.​1056/​NEJMoa1414905 CrossRefPubMed
6.
Zurück zum Zitat Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, SWIFT PRIME Investigators et al (2015) Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 372:2285–2295. doi:10.1056/NEJMoa1415061 CrossRefPubMed Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, SWIFT PRIME Investigators et al (2015) Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 372:2285–2295. doi:10.​1056/​NEJMoa1415061 CrossRefPubMed
7.
Zurück zum Zitat Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, REVASCAT Trial Investigators et al (2015) Thrombectomy within 8 h after symptom onset in ischemic stroke. N Engl J Med 372:2296–2306. doi:10.1056/NEJMoa1503780 CrossRefPubMed Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, REVASCAT Trial Investigators et al (2015) Thrombectomy within 8 h after symptom onset in ischemic stroke. N Engl J Med 372:2296–2306. doi:10.​1056/​NEJMoa1503780 CrossRefPubMed
11.
Zurück zum Zitat Desilles JP, Loyau S, Syvannarath V, Gonzalez-Valcarcel J, Cantier M, Louedec L et al (2015) Alteplase reduces downstream microvascular thrombosis and improves the benefit of large artery recanalization in stroke. Stroke 46:3241–3248. doi:10.1161/STROKEAHA.115.010721 CrossRefPubMed Desilles JP, Loyau S, Syvannarath V, Gonzalez-Valcarcel J, Cantier M, Louedec L et al (2015) Alteplase reduces downstream microvascular thrombosis and improves the benefit of large artery recanalization in stroke. Stroke 46:3241–3248. doi:10.​1161/​STROKEAHA.​115.​010721 CrossRefPubMed
12.
Zurück zum Zitat Cheng B, Golsari A, Fiehler J, Rosenkranz M, Gerloff C, Thomalla G (2011) Dynamics of regional distribution of ischemic lesions in middle cerebral artery trunk occlusion relates to collateral circulation. J Cereb Blood Flow Metab 31:36–40. doi:10.1038/jcbfm.2010.185 CrossRefPubMed Cheng B, Golsari A, Fiehler J, Rosenkranz M, Gerloff C, Thomalla G (2011) Dynamics of regional distribution of ischemic lesions in middle cerebral artery trunk occlusion relates to collateral circulation. J Cereb Blood Flow Metab 31:36–40. doi:10.​1038/​jcbfm.​2010.​185 CrossRefPubMed
13.
15.
Zurück zum Zitat Broeg-Morvay A, Mordasini P, Bernasconi C, Bühlmann M, Pult F, Arnold M et al (2016) Direct mechanical intervention versus combined intravenous and mechanical intervention in large artery anterior circulation stroke: a matched-pairs analysis. Stroke 47:1037–1044. doi:10.1161/STROKEAHA.115.011134 CrossRefPubMed Broeg-Morvay A, Mordasini P, Bernasconi C, Bühlmann M, Pult F, Arnold M et al (2016) Direct mechanical intervention versus combined intravenous and mechanical intervention in large artery anterior circulation stroke: a matched-pairs analysis. Stroke 47:1037–1044. doi:10.​1161/​STROKEAHA.​115.​011134 CrossRefPubMed
17.
Zurück zum Zitat Abilleira S, Ribera A, Cardona P, Rubiera M, López-Cancio E, Amaro S, Catalan Stroke Code and Reperfusion Consortium et al (2017) Outcomes after direct thrombectomy or combined intravenous and endovascular treatment are not different. Stroke 48:375–378. doi:10.1161/STROKEAHA.116.015857 CrossRefPubMed Abilleira S, Ribera A, Cardona P, Rubiera M, López-Cancio E, Amaro S, Catalan Stroke Code and Reperfusion Consortium et al (2017) Outcomes after direct thrombectomy or combined intravenous and endovascular treatment are not different. Stroke 48:375–378. doi:10.​1161/​STROKEAHA.​116.​015857 CrossRefPubMed
18.
Zurück zum Zitat Rai AT, Boo S, Buseman C, Adcock AK, Tarabishy AR, Miller MM, Roberts TD et al (2017) Intravenous thrombolysis before endovascular therapy for large vessel strokes can lead to significantly higher hospital costs without improving outcomes. Neurointerv Surg. doi:10.1136/neurintsurg-2016-012830 Rai AT, Boo S, Buseman C, Adcock AK, Tarabishy AR, Miller MM, Roberts TD et al (2017) Intravenous thrombolysis before endovascular therapy for large vessel strokes can lead to significantly higher hospital costs without improving outcomes. Neurointerv Surg. doi:10.​1136/​neurintsurg-2016-012830
19.
Zurück zum Zitat Coutinho JM, Liebeskind DS, Slater LA, Nogueira RG, Clark W, Dávalos A et al (2017) Combined intravenous thrombolysis and thrombectomy vs thrombectomy alone for acute ischemicstroke: a pooled analysis of the SWIFT and STAR studies. JAMA Neurol 74:268–274. doi:10.1001/jamaneurol.2016.5374 CrossRefPubMed Coutinho JM, Liebeskind DS, Slater LA, Nogueira RG, Clark W, Dávalos A et al (2017) Combined intravenous thrombolysis and thrombectomy vs thrombectomy alone for acute ischemicstroke: a pooled analysis of the SWIFT and STAR studies. JAMA Neurol 74:268–274. doi:10.​1001/​jamaneurol.​2016.​5374 CrossRefPubMed
20.
Zurück zum Zitat Sallustio F, Koch G, Di Legge S, Rossi C, Rizzato B, Napolitano S et al (2013) Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience. J Stroke Cerebrovasc Dis 22:e323–e331. doi:10.1016/j.jstrokecerebrovasdis.2013.01.001 CrossRefPubMed Sallustio F, Koch G, Di Legge S, Rossi C, Rizzato B, Napolitano S et al (2013) Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience. J Stroke Cerebrovasc Dis 22:e323–e331. doi:10.​1016/​j.​jstrokecerebrova​sdis.​2013.​01.​001 CrossRefPubMed
21.
Zurück zum Zitat Pexman JH, Barber PA, Hill MD, Sevick RJ, Demchuk AM, Hudon ME et al (2001) Use of the alberta stroke program early CT score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol 22:1534–1542PubMed Pexman JH, Barber PA, Hill MD, Sevick RJ, Demchuk AM, Hudon ME et al (2001) Use of the alberta stroke program early CT score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol 22:1534–1542PubMed
23.
Zurück zum Zitat Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Peripheral Vascular Disease, Council on Clinical Cardiology et al (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44:870–947. doi:10.1161/STR.0b013e318284056a CrossRefPubMed Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Peripheral Vascular Disease, Council on Clinical Cardiology et al (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44:870–947. doi:10.​1161/​STR.​0b013e318284056a​ CrossRefPubMed
24.
27.
Zurück zum Zitat Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41CrossRefPubMed Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41CrossRefPubMed
28.
Zurück zum Zitat Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology, Technology Assessment Committee of the Society of Interventional Radiology et al (2003) Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 34:e109–137CrossRefPubMed Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology, Technology Assessment Committee of the Society of Interventional Radiology et al (2003) Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 34:e109–137CrossRefPubMed
29.
Zurück zum Zitat Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R et al (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274:1017–1025CrossRefPubMed Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R et al (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274:1017–1025CrossRefPubMed
30.
Zurück zum Zitat Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, ECASS Investigators et al (2008) Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke. N Engl J Med 359:1317–1329. doi:10.1056/NEJMoa0804656 CrossRefPubMed Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, ECASS Investigators et al (2008) Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke. N Engl J Med 359:1317–1329. doi:10.​1056/​NEJMoa0804656 CrossRefPubMed
31.
Zurück zum Zitat Park HK, Chung JW, Hong JH, Jang MU, Noh HD, Park JM et al (2017) Preceding intravenous thrombolysis in patients receiving endovascular therapy. Cerebrovasc Dis 44:51–58. doi:10.1159/000471492 CrossRefPubMed Park HK, Chung JW, Hong JH, Jang MU, Noh HD, Park JM et al (2017) Preceding intravenous thrombolysis in patients receiving endovascular therapy. Cerebrovasc Dis 44:51–58. doi:10.​1159/​000471492 CrossRefPubMed
32.
Zurück zum Zitat Maier IL, Behme D, Schnieder M, Tsogkas I, Schregel K, Kleinknecht A et al (2017) Bridging-therapy with intravenous recombinant tissue plasminogen activator improves functional outcome in patients with endovascular treatment in acute stroke. J Neurol Sci 372:300–304. doi:10.1016/j.jns.2016.12.001 CrossRefPubMed Maier IL, Behme D, Schnieder M, Tsogkas I, Schregel K, Kleinknecht A et al (2017) Bridging-therapy with intravenous recombinant tissue plasminogen activator improves functional outcome in patients with endovascular treatment in acute stroke. J Neurol Sci 372:300–304. doi:10.​1016/​j.​jns.​2016.​12.​001 CrossRefPubMed
33.
Zurück zum Zitat Pfefferkorn T, Holtmannspötter M, Patzig M, Brückmann H, Ottomeyer C, Opherk C, Dichgans M, Fesl G (2012) Preceding intravenous thrombolysis facilitates endovascular mechanical recanalization in large intracranial artery occlusion. Int J Stroke 7:14–18. doi:10.1111/j.1747-4949.2011.00639.x CrossRefPubMed Pfefferkorn T, Holtmannspötter M, Patzig M, Brückmann H, Ottomeyer C, Opherk C, Dichgans M, Fesl G (2012) Preceding intravenous thrombolysis facilitates endovascular mechanical recanalization in large intracranial artery occlusion. Int J Stroke 7:14–18. doi:10.​1111/​j.​1747-4949.​2011.​00639.​x CrossRefPubMed
Metadaten
Titel
Short and long-term outcomes after combined intravenous thrombolysis and mechanical thrombectomy versus direct mechanical thrombectomy: a prospective single-center study
verfasst von
Giovanni Merlino
Massimo Sponza
Benedetto Petralia
Alessandro Vit
Vladimir Gavrilovic
Andrea Pellegrin
Michele Rana
Iacopo Cancelli
Sara Naliato
Simone Lorenzut
Roberto Marinig
Ferdinando Calzolari
Roberto Eleopra
Publikationsdatum
12.07.2017
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 2/2017
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-017-1527-8

Weitere Artikel der Ausgabe 2/2017

Journal of Thrombosis and Thrombolysis 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.